Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03432676
Title Study of IDO-1 Inhibitor Epacadostat in Combination With Pembrolizumab in Advanced Pancreatic Cancer With Chromosomal Instability/ Homologous Recombination Repair Deficiency (HRD)
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors M.D. Anderson Cancer Center
Indications

pancreatic ductal adenocarcinoma

pancreatic adenocarcinoma

Therapies

Epacadostat + Pembrolizumab

Age Groups: adult | senior
Covered Countries

Additional content available in CKB BOOST